Overview

The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol

Status:
Completed
Trial end date:
2021-06-08
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of Annovera and tampon co-usage on the pharmacokinetics (PK) of segesterone acetate (SA) and ethinyl estradiol (EE).
Phase:
Phase 1
Details
Lead Sponsor:
TherapeuticsMD
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Ethinyl Estradiol
Polyestradiol phosphate
ST 1435